Secondary prevention of coronary heart disease in Aboriginal and Torres Strait Islander people in primary care

Documenti analoghi

• Is semaglutide cost‐effective at closing the gap for Aboriginal and Torres Strait Islander Australians with cardiovascular disease and obesity without type 2 diabetes?
  di: Satyen Hargovan, et al.
  Pubblicazione: (2025)
• Semaglutide for Aboriginal and Torres Strait Islander cardiovascular care: equity, cost and real‐world hurdles
  di: Muhammad Mohsin Sami, et al.
  Pubblicazione: (2026)
• Evaluation of preventive medicine amongst people living with human immunodeficiency virus attending a hospital‐based care setting
  di: Manoshi Perera, et al.
  Pubblicazione: (2025)
• Not just skin deep: reframing chronic inflammatory skin disease as a systemic threat
  di: Annika Smith, et al.
  Pubblicazione: (2025)
• Implementing early detection of cognitive impairment in primary care to improve care for older adults
  di: Nicole R. Fowler, et al.
  Pubblicazione: (2025)